Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute?

A public economics framework is used to consider how pharmaceuticals should be priced when at least some of the research and development incentive comes from sales revenues. Familiar techniques of public finance are used to relax some of the restri...

Full description

Bibliographic Details
Main Authors: Jack, William, Lanjouw, Jean O.
Language:English
en_US
Published: Published by Oxford University Press on behalf of the World Bank 2014
Subjects:
TAX
WTO
Online Access:http://documents.worldbank.org/curated/en/2005/01/17747581/financing-pharmaceutical-innovation-much-poor-countries-contribute
http://hdl.handle.net/10986/16481